Table 2.

General opinion regarding efficacy of nutritional supplements in age-related macular degeneration

	Early/intermediate stages	Geographic atrophy stage	Neovascular atrophy stage
To slow progression	14/20 (14.5 versus 13.7)	10.2/20 (10.5 versus 9.9)	8.7/20 (8.8 versus 8.7)
To stop progression	8.2/20 (8.8 versus 7.6)	6.0/20 (6.5 versus 5.5)	5.0/20 (5.3 versus 4.7)
To reduce lesions, damage	8.5/20 (8.7 versus 8.2)	6.5/20 (6.5 versus 6.5)	6.1/20 (6.2 versus 6.0)

Notes: 1= very bad opinion; 20= excellent/best possible opinion. Numbers in parentheses are general ophthalmologist versus retinal specialist scores.